Prognostic factors and mortality among adult patients with acute leukemia and infection;Factores pronosticos y mortalidad en pacientes adultos con leucemia aguda e infeccion

Medicina

Volumn 57, Issue 5, 1997, Pages 557-565

  Brodsky, Andres L ^a   Melero, Marcelo J ^a,b   Minissale, Clelia ^a   Sanchez Avalos, Julio C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CROSS INFECTION; FEMALE; FEVER; HUMAN; LEUKEMIA; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; CROSS INFECTION; FEMALE; FEVER; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0031310227     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gale RP, Hoffbrand AV. Acute leukaemias: biology and treatment Clinics in Haernatology 1986; 15: 567-71.
2. Santos GW. Marrow transplantation in acute non lymphocytic leukemia. Blood 1989; 74: 901-8.
3. Champlin R, Gale RP. Acute lymphoblastic leukemia: recent advances in biology and treatment. Blood 1989; 73, 2051-66.
4. Gale RP, Foon KA. Acute myeloid leukaemia: recent advances in therapy. Clinics in Haematology 1986; 15: 781-809.
5. Hoelzer D, Thiel H, Lōffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123-31.
6. Young LS. Management of infections in leukemia and lymphoma. In Clinical Approach to Infections in the Compromised Host. Rubin RH, Young LS (eds). New York: Plenun Medical Book Co. 1988; 467-501.
7. Brodsky AL, Minissale CJ, Melero MJ, Sánchez Avalos JC. Profilaxis con fluoroquinolonas en pacientes neutropénicos. Medicine (Buenos Aires), 1993; 53: 401-7.
8. Sodey GP, Rodriguez V, Chang H, et al. Fever and infections in leukemic patients. Cancer 1978; 41: 1610-22.
9. Wang Qi-nan, Qiu Zhong-da. Infection in acute leukemia: an analysis of 433 episodes. Rev Infect Dis 1989; 2: 1613-20.
10. O'Hanley P, Eaw J, Rugo H, et al. Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital. Am J Med 1989; 605-13.
11. Brodsky A, Melero M, Minissale C, Sánchez Avalos JC. Infecciones afebriles en pacientes adultos con leucemia aguda. Medicina (Buenos Aires) 1995; 55: 193-6.
12. Pizzo PA, Robichaud RN, Wesley R, et al. Fever in the pediatric and young adult patient with cancer. Medicine. 1982; 61: 153-65.
13. Meunier F. Infection in patients with acute leukemia and lymphoma. In Mandell, Doublas and Bemett's Principles and Practice of Infectious Diseases. L. Mandell et al (eds). New York: Churchill Livingstone Inc. 1995, 2675-86.
14. Talcott JA, Finberg R, Mayer RJ, et al. The medical course of cancer patients with fever and neutropenia: clinical identification of a low risk subgroup at presentation. Arch Intern Med 1988; 148: 2561-8.
15. Mullen CA, Buchanan GR. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. J Clin Oncol 1990; 8: 1998-2004.
16. Gardembas-Pain M, Desabiens B, Sensebe L, et al. Home treatment of febrile neutropenia: an empirical oral antibiotic regimen. Ann Oncol 1991; 2: 485-7.
17. Griffin TC, Buchanan GR. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from hospital. J Pediatr 1992; 121: 28-33.
18. Talcott JA, Siegel RD, Finberg R, et al. Risk assessment in cancer patients with fever and neutropenia: A prospective, two center validation of a prediction rule. J Clin Oncol 1992; 10:316-22.
19. Rubenstein EB, Rolsion K, Benjamin RS, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer. 1993; 71: 3640-6.
20. Bash RO, Katz JA, Cash RN, et al. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer 1994; 74: 189-96.
21. Malik I, Khan WA, Aziz A, Karim M. Self-administered antibiotic therapy for chemotherapy induced low-risk febrile neutropenia in patients with non-hematologic neoplasm. Clin Infect Dis 1994; 19: 522-7.
22. Talcott JA, Whalen A, Clark J, et al. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994; 12: 107-14.
23. Malik IA, Khan WA, Karim M, et al. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995; 98: 224-31.
24. De Gregorio M, Lee W, Ries C. Fungal infections in patients with acute leukemia. Am J Med 1982; 73: 543-5.
25. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-72.
26. Martino P, Girmenia C. Fungemia in patients with leukemia. Am J Med Sci 1993; 306: 225-32.
27. Dombret H, Chastang C, Fenaux P, et al. A controlled study of recombinant human granulocyte colonystimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med 1995; 332: 1678-83.
28. Stone RM, Berg DT, George SL, et al. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 1995; 332: 671-7.
29. Jarvis WR. The epidemiology of colonization. infect Control Hosp Epidemiol 1996; 17: 47-52.
30. Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Part II. Recommendations for isolation precautions in hospitals. Am J Infect Control 1996; 24: 32-52.
31. Gutiérrez J, Vargas N, Bronfman L, et al. Tratamiento de la leucemia aguda. Utilidad de una unidad de inmunocomprometidos. Rev Med Chile 1990; 118: 280-8.